Cyclazocine is a synthetic compound classified as a benzomorphan derivative, primarily known for its use as an analgesic and its potential as a research tool in pharmacology. It exhibits a complex pharmacological profile, acting as a partial agonist at the mu-opioid receptor while also displaying antagonist properties at the kappa-opioid receptor. This dual action contributes to its analgesic effects, but it may also lead to unique side effects compared to traditional opioids. Cyclazocine is characterized by its ability to induce sedation and analgesia, but it can also provoke dysphoria in some individuals, which limits its clinical use. The compound has a relatively low oral bioavailability and is often administered via injection in research settings. Its chemical structure includes a nitrogen atom in a piperidine ring, contributing to its interaction with opioid receptors. Due to its complex effects and potential for abuse, cyclazocine is subject to regulatory scrutiny, and its use is primarily confined to laboratory research rather than widespread clinical application.

Cyclazocine

3572-80-3: 3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol, NSC 107429, 2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-, Win 20740, Cyclazocine

Cyclazocine is an analgesic with mixed narcotic agonist-antagonist properties.

Please enquire for more information about Cyclazocine including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 3572-80-3: Cyclazocine

Cyclazocine

Ref: TM-T69370

Cyclazocine

Ref: 3D-DAA57280

Cyclazocine

Ref: TR-LGCFOR3016.00